Cargando…
Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585751/ https://www.ncbi.nlm.nih.gov/pubmed/30117173 http://dx.doi.org/10.1002/hon.2548 |
_version_ | 1783428765678829568 |
---|---|
author | Ma, Ling Xu, Shuang Qu, Jianhua Hou, Jian Wang, Yang Wen, Lei Liu, Yang Kang, Ying Jiang, Ming Fu, Weijun Du, Juan Zhou, Lin Huang, Xiaojun Zhang, Zhaoxia Lu, Jin |
author_facet | Ma, Ling Xu, Shuang Qu, Jianhua Hou, Jian Wang, Yang Wen, Lei Liu, Yang Kang, Ying Jiang, Ming Fu, Weijun Du, Juan Zhou, Lin Huang, Xiaojun Zhang, Zhaoxia Lu, Jin |
author_sort | Ma, Ling |
collection | PubMed |
description | The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence of different age groups was 1.19% (41‐50 y), 1.16% (51‐60 y), 2.19% (61‐70 y), 3.66% (71‐80 y), and 7.76% (≥81 y). The prevalence of MGUS in male (n = 843) was 2.97%, while the prevalence of MGUS in female (n = 952) was 2.52%, but this difference of the two groups was not statistically significant. As for subtype of MGUS, IgG subtype was 55.1% (27 cases), IgA subtype was 14.3%, and IgM subtype was 12.2%. The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow‐up duration: 3‐7 mo). Thus, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American Whites, American Blacks, and Africans, and had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG. |
format | Online Article Text |
id | pubmed-6585751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65857512019-06-27 Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study Ma, Ling Xu, Shuang Qu, Jianhua Hou, Jian Wang, Yang Wen, Lei Liu, Yang Kang, Ying Jiang, Ming Fu, Weijun Du, Juan Zhou, Lin Huang, Xiaojun Zhang, Zhaoxia Lu, Jin Hematol Oncol Original Research Articles The aim of this study was to identify the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in different groups of age and the clinical features in China. This multicenter prospective study enrolled 1797 health subjects. The overall prevalence of MGUS was 2.73%. The prevalence of different age groups was 1.19% (41‐50 y), 1.16% (51‐60 y), 2.19% (61‐70 y), 3.66% (71‐80 y), and 7.76% (≥81 y). The prevalence of MGUS in male (n = 843) was 2.97%, while the prevalence of MGUS in female (n = 952) was 2.52%, but this difference of the two groups was not statistically significant. As for subtype of MGUS, IgG subtype was 55.1% (27 cases), IgA subtype was 14.3%, and IgM subtype was 12.2%. The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow‐up duration: 3‐7 mo). Thus, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American Whites, American Blacks, and Africans, and had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG. John Wiley and Sons Inc. 2018-10-01 2019-02 /pmc/articles/PMC6585751/ /pubmed/30117173 http://dx.doi.org/10.1002/hon.2548 Text en © 2018 The Authors Hematological Oncology Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Articles Ma, Ling Xu, Shuang Qu, Jianhua Hou, Jian Wang, Yang Wen, Lei Liu, Yang Kang, Ying Jiang, Ming Fu, Weijun Du, Juan Zhou, Lin Huang, Xiaojun Zhang, Zhaoxia Lu, Jin Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title | Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title_full | Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title_fullStr | Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title_full_unstemmed | Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title_short | Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study |
title_sort | monoclonal gammopathy of undetermined significance in chinese population: a prospective epidemiological study |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585751/ https://www.ncbi.nlm.nih.gov/pubmed/30117173 http://dx.doi.org/10.1002/hon.2548 |
work_keys_str_mv | AT maling monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT xushuang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT qujianhua monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT houjian monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT wangyang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT wenlei monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT liuyang monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT kangying monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT jiangming monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT fuweijun monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT dujuan monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT zhoulin monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT huangxiaojun monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT zhangzhaoxia monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT lujin monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy AT monoclonalgammopathyofundeterminedsignificanceinchinesepopulationaprospectiveepidemiologicalstudy |